| PubMed |
Abstract |
RScore(About this table) |
| 18590823 |
Tsai LK, Tsai MS, Ting CH, Wang SH, Li H: Restoring Bcl-x (L) levels benefits a mouse model of spinal muscular atrophy. Neurobiol Dis. 2008 Sep;31(3):361-7. Epub 2008 Jun 3.
|
7(0,0,0,7) |
Details |
| 19525895 |
Martinez-Hernandez R, Soler-Botija C, Also E, Alias L, Caselles L, Gich I, Bernal S, Tizzano EF: The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. J Neuropathol Exp Neurol. 2009 May;68(5):474-81.
Here, we performed histological and morphometric analysis of myotubes and assessed DNA fragmentation and Bcl-2/Bcl-X (L) expression in skeletal muscle from fetuses with type I SMA (at approximately 12 and 15 weeks' gestational ages, n = 4) and controls (at approximately 10-15 weeks' gestational ages, n = 7). |
1(0,0,0,1) |
Details |
| 18649067 |
Tsai LK, Tsai MS, Ting CH, Li H: Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice. J Mol Med. 2008 Nov;86(11):1243-54. Epub 2008 Jul 23.
VPA also increased levels of anti-apoptotic factors, Bcl-2 and Bcl-x (L), in spinal neurons. |
1(0,0,0,1) |
Details |